journal article·2026-04-10

NIR-Triggered H 2 O 2 Release from LA-CP@Fe 3 O 4 Nanoparticles for Precise Antimicrobial Therapy and Wound Healing

Yue Wang, Long Zhang, Sijie Zhang, Shuyue Li, Xingyan Wang, Wenhao Liu, Feng Yang, Xueyi Liu, Yi Hao, Ruixia Gao, Sicen Wang, Jingang An

ACS Applied Nano Materials· Volume 9· Issue 14
Publisher page

Abstract

Bacterial infections pose a severe global health threat with rising mortality, driving the need for alternative therapies. Chemodynamic therapy (CDT), which converts endogenous H 2 O 2 into lethal hydroxyl radicals ( • OH) via Fenton reactions, offers a promising solution. Copper peroxide (CuO 2 ) nanodots have recently attracted considerable research interest because of their capacity to generate H 2 O 2 . Despite this advantage, their practical use in antibacterial applications is severely limited by their poor stability. In this study, we developed a near-infrared (NIR)-triggered nanoplatform, LA-CP@Fe 3 O 4, by encapsulating CuO 2 -loaded iron tetraoxide nanoparticles with the phase-change material lauric acid (LA). This system synergistically combines a Fe 2+ /Fe 3+ -Cu + /Cu 2+ dual-metal catalytic network for enhanced • OH generation with NIR-triggered photothermal activation (a photothermal conversion efficiency of 39.21%), allowing spatiotemporally controlled therapeutic release while stabilizing CuO 2 nanodots. In vitro, the platform achieved 99.9% bactericidal efficiency via self-supplied H 2 O 2 and targeted ROS generation. In vivo, it exhibited excellent biocompatibility, accelerated wound healing with an 88.0% reduction in wound area by day 7, and effective NIR-triggered antibacterial activity. These results collectively establish a groundbreaking approach for precision antibacterial therapy with strong clinical translation potential.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Wound Healing and Treatments · Advanced Photocatalysis Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Pharmacy, Health Science Center

Xi’an Jiaotong University

Department of Dermatology

The Second Affiliated Hospital of Xi’an Jiaotong University

School of Chemistry

Zhejiang Fangyuan Test Group Co., Ltd.

Funding

Xi?an Jiaotong University · National Key Research and Development Program of China · China Postdoctoral Science Foundation · National Natural Science Foundation of China · Natural Science Foundation of Shaanxi Province

References (38)

Show source-provided references
1. 10.1136/bmjgh-2019-00210410.1136/bmjgh-2019-002104 ↗
2. 10.1126/science.abl599710.1126/science.abl5997 ↗
3. 10.1016/S0140-6736(21)02724-010.1016/S0140-6736(21)02724-0 ↗
4. 10.1007/s10123-021-00184-y10.1007/s10123-021-00184-y ↗
5. 10.1038/302657a010.1038/302657a0 ↗
6. 10.1038/s41579-022-00820-y10.1038/s41579-022-00820-y ↗
7. 10.1002/adma.20241873110.1002/adma.202418731 ↗
8. 10.1002/smll.20210386810.1002/smll.202103868 ↗
9. 10.1016/j.jconrel.2020.06.00310.1016/j.jconrel.2020.06.003 ↗
10. 10.1002/smll.20250452410.1002/smll.202504524 ↗
11. 10.1021/jacs.9b0345710.1021/jacs.9b03457 ↗
12. 10.1039/D3NR05458F10.1039/D3NR05458F ↗
13. 10.1021/acsami.1c0241310.1021/acsami.1c02413 ↗
14. 10.1016/j.actbio.2022.12.04110.1016/j.actbio.2022.12.041 ↗
15. 10.1039/c3cs35469e10.1039/c3cs35469e ↗
16. 10.1016/j.cej.2022.13788910.1016/j.cej.2022.137889 ↗
17. 10.1016/j.nantod.2025.10277210.1016/j.nantod.2025.102772 ↗
18. 10.1021/acsami.4c0982010.1021/acsami.4c09820 ↗
19. 10.1016/j.cej.2023.14531610.1016/j.cej.2023.145316 ↗
20. 10.1002/adfm.20240786910.1002/adfm.202407869 ↗
21. 10.1021/acsami.3c1190310.1021/acsami.3c11903 ↗
22. 10.1002/agt2.58710.1002/agt2.587 ↗
23. 10.1039/D3TB02762G10.1039/D3TB02762G ↗
24. 10.1016/j.actbio.2024.03.01410.1016/j.actbio.2024.03.014 ↗
25. 10.1021/acsami.4c1518710.1021/acsami.4c15187 ↗
26. 10.1016/j.biomaterials.2025.12353810.1016/j.biomaterials.2025.123538 ↗
27. 10.1021/acsami.4c1796610.1021/acsami.4c17966 ↗
28. 10.1016/j.jcis.2025.13830110.1016/j.jcis.2025.138301 ↗
29. 10.1016/j.est.2024.11374710.1016/j.est.2024.113747 ↗
30. 10.1021/acsnano.1c1023110.1021/acsnano.1c10231 ↗
31. 10.1126/sciadv.abc437310.1126/sciadv.abc4373 ↗
32. 10.1016/j.actbio.2023.12.00410.1016/j.actbio.2023.12.004 ↗
33. 10.1016/j.actbio.2024.04.04110.1016/j.actbio.2024.04.041 ↗
34. 10.1021/acsami.4c1738810.1021/acsami.4c17388 ↗
35. 10.1002/smll.20250151110.1002/smll.202501511 ↗
36. 10.1021/acsnano.5c0768610.1021/acsnano.5c07686 ↗
37. 10.1002/adma.20230134910.1002/adma.202301349 ↗
38. 10.1016/j.actbio.2024.05.01510.1016/j.actbio.2024.05.015 ↗